Second Affiliated Hospital of Wenzhou Medical University
Phase
Observational
Started
2020-01-01
Last updated
2026-03-11
Condition(s) studied
Pregnancy-induced Hypertension
Investigational drug(s) / intervention(s)
no Intervention
no Intervention: observation
Study summary
Collect blood pressure, blood, amniotic fluid, placenta and other samples from normal pregnant women, patients with pregnancy-induced hypertension and those who have experienced miscarriage, and conduct tests on them.
Eligibility
Sex
FEMALE
Min age
20 Years
Max age
50 Years
Healthy volunteers
Accepted
Inclusion Criteria:
\- Healthy pregnant women, patients with miscarriage, etc.
Exclusion Criteria:
* Heart disease, infections, etc. in pregnant women Uncooperative patients
Primary outcome measure(s)
PIH — Early pregnancy：Weeks 1 to 12 (the first to third months of pregnancy) ；mid-pregnancy：Weeks 13 to 27 (the 4th to 6th month of pregnancy) ；post-delivery period：Weeks 28 to 40 (the 7th to 9th months of pregnancy)；the day of delivery。 the content of GPR18 type macrophages
Trial sites (1)
Facility
City
Region
Status
The Second Affiliated Hospital of Wenzhou Medical University
Wenzhou
Zhejiang
Recruiting
More Second Affiliated Hospital of Wenzhou Medical University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.